Transforming India’s Biopharmaceutical Landscape: The Expanding Role Of Biosimilars In Cost-Effective Healthcare

The development of biological treatments has changed the treatment modality for chronic diseases and diseases that could be life-threatening, but the issue is the exorbitant cost, making them inaccessible, especially in underdeveloped and developing countries. Biosimilars present an effective solution that is equally safe, effective, and of equal quality compared to biologics, hence offering affordable healthcare. This article examines the movement from biologicals to biosimilars, highlighting the science behind them, their regulation, and validation. The article also notes the growing bioeconomy in India, involvement of local pharmaceutical companies, and initiatives by the Indian government to encourage the development of biosimilars and advances in drug delivery systems.